CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Acadia Pharmaceuticals, Inc. Company Snapshot
Acadia Pharmaceuticals, Inc. operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Acadia Pharmaceuticals with three other companies in this sector in the United States: Amarin Corporation PLC (2018 sales of $229.21 million of which 100% was Research&Development), FibroGen Inc ($212.96 million of which 100% was Biopharmaceutical Preparations), and Eagle Pharmaceuticals, Inc ($213.31 million of which 100% was Pharmaceuticals).

Sales Analysis. Acadia Pharmaceuticals reported sales of $223.81 million for the year ending December of 2018. This represents an increase of 79.2% versus 2017, when the company's sales were $124.90 million. This was the third consecutive year of growth at Acadia Pharmaceuticals.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Acadia Pharmaceuticals, Inc.
  Stock Performance Chart for Acadia Pharmaceuticals, Inc.
 
  Stock Data: Recent Stock Performance:
  Current Price (10/11/2019): 40.52
(Figures in U.S. Dollars)
1 Week 6.2%   13 Weeks 0.2%  
4 Weeks 48.8%   52 Weeks 86.6%  
 
Acadia Pharmaceuticals, Inc. Key Data:
  Ticker: ACAD Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 223,807,000
(Year Ending Jan 2019).
Employees: 430
  Currency: U.S. Dollars Market Cap: 5,853,281,348
  Fiscal Yr Ends: December Shares Outstanding: 144,454,130
  Share Type: Common Closely Held Shares: 413,629
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.